 After setbacks with the FDA, Heron finally launched Zynrelef in July with a constricted label to market. I believe Zynrelef might struggle in its first few quarters on the market. Heron is looking to broaden Zynrelefs label with supplementary studies. In addition, the company has given Zynrelef a competitive price tag to help improve coverage. 